First COVID-19 Human Challenge Trial Reveals Uneven Susceptibility
First COVID-19 Human Challenge Trial Reveals Uneven Susceptibility
Only half of volunteers deliberately exposed to SARS-CoV-2 developed an infection. None developed serious symptoms, paving the way for further challenge trials.
Only half of volunteers deliberately exposed to SARS-CoV-2 developed an infection. None developed serious symptoms, paving the way for further challenge trials.
challenge trials
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Jef Akst | Jun 18, 2021 | 4 min read
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
A Challenge Trial for COVID-19 Would Not Be the First of Its Kind
Jef Akst | Oct 8, 2020 | 9 min read
Although scientists debate the ethics of deliberately infecting volunteers with SARS-CoV-2, plenty of consenting participants have been exposed to all sorts of pathogens in prior trials.